Investor insights
Sectors invested in
Immunology1
Cell and Gene Therapy1
Health Care1
Clinical Trials1
Oncology1
T cell Antigen Coupler1
Clinical Developement1
Partnerships1
Funding rounds participated in
$35M sweet spot round size
Most of their 2 investments are in rounds between $24M and $45M
Investor type
Venture Capital
Basic info
Industry
investment management
Sectors
Semantic Web
Biotechnology
Health Care
Date founded
2020
Investments made
T
Triumvira Immunologics, Inc. raised $45M on March 17, 2022
Investors: B Capital Group, Northpond Ventures, Multiple Myeloma Research Foundation - MMRF, Leaps by Bayer and ATEM Capital
U
Undisclosed raised $24M on March 16, 2021
Investors: Longley Capital, -, Pritzker Vlock Family Office, JSR Corporation, LifeSci Venture Partners, Validus Growth Investors, LLC and ATEM Capital